C4 Therapeutics (CCCC)
US Market

C4 Therapeutics Financial Statements


C4 Therapeutics Financial Overview

C4 Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.04; its P/E ratio is -5.94; C4 Therapeutics is scheduled to report earnings on November 17, 2022, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 13.83M$ 7.65M$ 20.08M$ 8.50M$ 9.78M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -26.88M$ -31.09M$ -15.12M$ -24.14M$ -22.05M
EBITDA$ -26.44M$ -30.79M$ -14.80M$ -23.81M$ -21.66M
Net Income Common Stockholders$ -27.41M$ -31.62M$ -15.66M$ -24.68M$ -22.58M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 199.41M$ 291.17M$ 307.78M$ 309.28M$ 313.48M
Total Assets$ 492.48M$ 515.49M$ 506.76M$ 507.91M$ 528.42M
Total Debt$ 22.51M$ 22.68M$ 22.85M$ 23.01M$ 23.15M
Net Debt$ -176.91M$ -268.49M$ -284.93M$ -286.27M$ -290.33M
Total Liabilities$ 147.88M$ 150.96M$ 117.16M$ 109.13M$ 111.99M
Stockholders Equity$ 263.70M$ 280.79M$ 344.59M$ 364.53M$ 389.61M
Cash Flow
Free Cash Flow$ -22.72M$ -26.77M$ -25.78M$ -18.36M$ -18.75M
Operating Cash Flow$ -22.20M$ -26.60M$ -25.67M$ -18.36M$ -18.00M
Investing Cash Flow$ 33.23M$ -4.00M$ -59.41M$ -100.63M$ 32.43M
Financing Cash Flow$ 259.00K$ 480.00K$ 466.00K$ 584.00K$ 170.50M
Currency in USD

C4 Therapeutics Earnings and Revenue History

C4 Therapeutics Debt to Assets

C4 Therapeutics Cash Flow

C4 Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis